Showing results (21-30 of 785) with videos related to
Sort By:
Pageof 79
Current Cardiology Reports|May 2, 2007
Right ventricular failure complicating heart failure: pathophysiology, significance, and management strategiesMobusher Mahmud, Hunter C ChampionPhysics in Medicine and Biology|November 3, 2007
Positron follow-up in liquid water: II. Spatial and energetic study for the most important radioisotopes used in PETC Champion, C Le LoirecJournal of General Microbiology|October 1, 1990
Transfer of plasmid DNA to Brevibacterium lactofermentum by electrotransformationS Bonnassie, J F Burini, J Oreglia, et al.Life Sciences|January 1, 1997
[Tyr1]-nociceptin has naloxone-insensitive vasodilator activity in the hindquarters vascular bed of the ratH C Champion, P J KadowitzCanadian Journal of Physiology and Pharmacology|August 25, 2000
Vasodilator responses to ATP and UTP are not dependent on nitric oxide release, K+(ATP) channel activation, or the release of vasodilator prostaglandins in the hindlimb vascular bed of the catH C Champion, P J KadowitzThe American Journal of Physiology|June 5, 1998
D-[Ala2]endomorphin 2 and endomorphin 2 have nitric oxide-dependent vasodilator activity in ratsH C Champion, P J KadowitzEuropean Journal of Pharmacology|May 7, 1998
R-(-)-alpha-methyl-histamine has nitric oxide-mediated vasodilator activity in the mesenteric vascular bed of the catH C Champion, P J KadowitzLife Sciences|January 1, 1997
Nociceptin, an endogenous ligand for the ORL1 receptor, has novel hypotensive activity in the ratH C Champion, P J KadowitzThe American Journal of Physiology|August 1, 1997
NO release and the opening of K+ATP channels mediate vasodilator responses to histamine in the catH C Champion, P J KadowitzExpert Review of Cardiovascular Therapy|May 24, 2006
Sildenafil, a PDE5 inhibitor, in the treatment of pulmonary hypertensionAnna R Hemnes, Hunter C ChampionPageof 79